RU2015155831A - Аденилатциклаза, некомпетентная по циклическому аденозин монофосфату, композиция и способы для лечения сердечной недостаточности и улучшения сердечной функции - Google Patents
Аденилатциклаза, некомпетентная по циклическому аденозин монофосфату, композиция и способы для лечения сердечной недостаточности и улучшения сердечной функции Download PDFInfo
- Publication number
- RU2015155831A RU2015155831A RU2015155831A RU2015155831A RU2015155831A RU 2015155831 A RU2015155831 A RU 2015155831A RU 2015155831 A RU2015155831 A RU 2015155831A RU 2015155831 A RU2015155831 A RU 2015155831A RU 2015155831 A RU2015155831 A RU 2015155831A
- Authority
- RU
- Russia
- Prior art keywords
- ac6mut
- gene
- cardiac
- nucleic acid
- heart
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y406/00—Phosphorus-oxygen lyases (4.6)
- C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
- C12Y406/01001—Aodenylate cyclase (4.6.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832759P | 2013-06-07 | 2013-06-07 | |
| US61/832,759 | 2013-06-07 | ||
| PCT/US2014/040948 WO2014197624A1 (en) | 2013-06-07 | 2014-06-04 | Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2015155831A true RU2015155831A (ru) | 2017-07-14 |
| RU2015155831A3 RU2015155831A3 (enExample) | 2018-03-28 |
Family
ID=52008569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015155831A RU2015155831A (ru) | 2013-06-07 | 2014-06-04 | Аденилатциклаза, некомпетентная по циклическому аденозин монофосфату, композиция и способы для лечения сердечной недостаточности и улучшения сердечной функции |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11040091B2 (enExample) |
| EP (1) | EP3004343B1 (enExample) |
| JP (1) | JP6571069B2 (enExample) |
| KR (1) | KR20160032090A (enExample) |
| CN (1) | CN105452458A (enExample) |
| AU (1) | AU2014274902B2 (enExample) |
| BR (1) | BR112015030355A8 (enExample) |
| CA (1) | CA2914029A1 (enExample) |
| DK (1) | DK3004343T3 (enExample) |
| HK (1) | HK1222884A1 (enExample) |
| IL (1) | IL242885B (enExample) |
| RU (1) | RU2015155831A (enExample) |
| WO (1) | WO2014197624A1 (enExample) |
| ZA (1) | ZA201508942B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6878301B2 (ja) * | 2015-04-09 | 2021-05-26 | コーネル ユニヴァーシティー | アレルゲンに対する反応を予防するための遺伝子治療 |
| EP3530278A4 (en) * | 2016-10-24 | 2019-10-30 | Gwangju Institute of Science and Technology | COMPOSITION WITH PROTEIN-PHOSPHATASE-1-INHIBITING PEPTIDE FOR THE TREATMENT OF VASCULAR DISEASES |
| WO2018090036A1 (en) * | 2016-11-14 | 2018-05-17 | Renova Therapeutics, Inc. | Method of protection for cardiac tissue |
| US11760987B2 (en) | 2017-09-07 | 2023-09-19 | The Regents Of The University Of California | Compositions and methods for the treatment or prevention of heart failure |
| EP3689363A4 (en) * | 2017-09-29 | 2021-05-19 | BethphaGen Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIAC ARRHYTHMIA |
| CN112272705A (zh) * | 2018-06-08 | 2021-01-26 | 佛罗里达大学研究基金会有限公司 | 用于心肌病的aav心脏基因治疗 |
| CN109010799B (zh) * | 2018-07-09 | 2021-07-06 | 沣潮医药科技（上海）有限公司 | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 |
| CN109191052B (zh) * | 2018-10-22 | 2020-09-25 | 山东大学 | 一种多车型车辆路径优化方法、服务器及系统 |
| MX2023001109A (es) | 2020-07-27 | 2023-04-24 | Anjarium Biosciences Ag | Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas. |
| CN116867512A (zh) | 2020-12-23 | 2023-10-10 | 佛罗里达州大学研究基金会 | 包装效率提高的用于心脏基因治疗的载体 |
| CN116411064A (zh) * | 2023-02-24 | 2023-07-11 | 山东大学齐鲁医院 | Gsα基因在制备用于预防和治疗动脉粥样硬化药物中的应用 |
| CN116590398A (zh) * | 2023-04-20 | 2023-08-15 | 青岛大学 | Atf7基因在制备心脏疾病诊断产品中的应用和药物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020103147A1 (en) | 1997-09-05 | 2002-08-01 | Hammond H. Kirk | Gene therapy for congestive heart failure |
-
2014
- 2014-06-04 BR BR112015030355A patent/BR112015030355A8/pt not_active Application Discontinuation
- 2014-06-04 KR KR1020167000315A patent/KR20160032090A/ko not_active Ceased
- 2014-06-04 HK HK16111093.5A patent/HK1222884A1/zh unknown
- 2014-06-04 CN CN201480044190.5A patent/CN105452458A/zh active Pending
- 2014-06-04 EP EP14808138.3A patent/EP3004343B1/en active Active
- 2014-06-04 CA CA2914029A patent/CA2914029A1/en not_active Abandoned
- 2014-06-04 DK DK14808138.3T patent/DK3004343T3/en active
- 2014-06-04 US US14/893,905 patent/US11040091B2/en active Active
- 2014-06-04 AU AU2014274902A patent/AU2014274902B2/en active Active
- 2014-06-04 RU RU2015155831A patent/RU2015155831A/ru not_active Application Discontinuation
- 2014-06-04 WO PCT/US2014/040948 patent/WO2014197624A1/en not_active Ceased
- 2014-06-04 JP JP2016517971A patent/JP6571069B2/ja active Active
-
2015
- 2015-12-02 IL IL242885A patent/IL242885B/en active IP Right Grant
- 2015-12-08 ZA ZA2015/08942A patent/ZA201508942B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1222884A1 (zh) | 2017-07-14 |
| BR112015030355A2 (pt) | 2017-07-25 |
| CA2914029A1 (en) | 2014-12-11 |
| JP2016521708A (ja) | 2016-07-25 |
| EP3004343B1 (en) | 2018-10-10 |
| US20160101164A1 (en) | 2016-04-14 |
| RU2015155831A3 (enExample) | 2018-03-28 |
| ZA201508942B (en) | 2019-05-29 |
| EP3004343A4 (en) | 2017-01-04 |
| IL242885B (en) | 2019-12-31 |
| KR20160032090A (ko) | 2016-03-23 |
| EP3004343A1 (en) | 2016-04-13 |
| AU2014274902B2 (en) | 2020-06-04 |
| CN105452458A (zh) | 2016-03-30 |
| US11040091B2 (en) | 2021-06-22 |
| AU2014274902A1 (en) | 2015-12-24 |
| BR112015030355A8 (pt) | 2019-12-24 |
| JP6571069B2 (ja) | 2019-09-04 |
| DK3004343T3 (en) | 2019-02-04 |
| WO2014197624A1 (en) | 2014-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521708A5 (enExample) | ||
| ES2735334T3 (es) | Señalización de complejo de hippo y distrofina en la renovación de cardiomiocitos | |
| KR102584655B1 (ko) | 조절성 폴리뉴클레오티드 | |
| EP3030666B1 (en) | Compositions and methods for treatment of muscular dystrophy | |
| EP3004343B1 (en) | Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function | |
| JP2020527333A (ja) | パーキンソン病を治療するためのａａｄｃポリヌクレオチド | |
| JP2015508760A5 (enExample) | ||
| US20240409955A1 (en) | Auf1 combination therapies for treatment of muscle degenerative disease | |
| CN114206351A (zh) | 用于人中心肌病的aav心脏基因治疗 | |
| JP2025523953A (ja) | 肢帯型筋ジストロフィーのためのａｕｆ１遺伝子療法 | |
| JP5850702B2 (ja) | 間葉系細胞の分化調節剤およびこれを用いた医薬、並びに間葉系細胞への分化調節作用を有する物質のスクリーニング方法 | |
| WO2016181011A1 (es) | Método para promover la regeneración muscular | |
| Katz et al. | Gene and protein-based therapies for improving cardiac performance and regeneration | |
| US20250387511A1 (en) | Aav2 variants and uses thereof | |
| EP4516286A1 (en) | Trehalose-based combined therapy for lysosomal damage | |
| WO2015153357A1 (en) | Compositions and methods for improving cardiac function | |
| Adjmi | Cardiomyocyte-Specific Delivery of hPKM2 modRNA via CM-SMRTs Drives Regeneration and Functional Recovery in a Porcine Model of Myocardial Infarction | |
| CN110475573A (zh) | 用于减少肌脂蛋白表达以及预防和治疗肌营养不良症和心肌病的组合物及其使用方法 | |
| Odom | Improving Cardiorespiratory Performance in DMD via Combinatorial Dystrophin and Ribonucleotide Reductase Gene Therapy | |
| Florit Gonzalez et al. | Past, Present and Future of Regenerative Gene Therapy for Ischemic Heart Failure | |
| Zhou | Developing A DWORF Micropeptide Gene Therapy For Heart Failure | |
| TW202603165A (zh) | 用於治療杜興氏肌肉失養症之腺相關病毒組成物 | |
| Handy | Follistatin Gene Therapy for the Treatment of Muscular Dystrophy | |
| Sugihara et al. | Relation between Voluntary Exercise Frequency and Cardiac Function in Dilated Cardiomyopathy Model Mice | |
| Kim et al. | Sarcolemmal nNOSµ targeting in mdx mice improves muscle function and restores dystrophin complex proteins via α-syntrophin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20201111 |